Reena Dholakia

Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab: A Phase 2 Clinical Trial.

L. Qin, C. Antonescu, S. Singer, 2020, JAMA oncology.

A phase II study of talimogene laherparepvec (T-VEC) and pembrolizumab in patients with metastatic sarcoma.

L. Qin, C. Antonescu, S. Singer, 2018 .